As a consequence, multiple myeloma cells showed expression of HLA-DR with no methylation in CIITA-PIV, perhaps making them a good target for CD4+ T-cells, which recognise antigen restricted by MHC class II molecules. Here, CD4 is linked to plasma cell myeloma.